Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.

Oncotarget

Mehta KY, Wu HJ, Menon SS, Fallah Y, Zhong X, Rizk N, Unger K, Mapstone M, Fiandaca MS, Federoff HJ, Cheema AK.
PMID: 28978166
Oncotarget. 2017 Aug 18;8(40):68899-68915. doi: 10.18632/oncotarget.20324. eCollection 2017 Sep 15.

Pancreatic cancer (PC) is an aggressive disease with high mortality rates, however, there is no blood test for early detection and diagnosis of this disease. Several research groups have reported on metabolomics based clinical investigations to identify biomarkers of...

Cite
Mehta KY, Wu HJ, Menon SS, et al. Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget. 2017;8(40):68899-68915doi: 10.18632/oncotarget.20324.
Mehta, K. Y., Wu, H. J., Menon, S. S., Fallah, Y., Zhong, X., Rizk, N., Unger, K., Mapstone, M., Fiandaca, M. S., Federoff, H. J., & Cheema, A. K. (2017). Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget, 8(40), 68899-68915. https://doi.org/10.18632/oncotarget.20324
Mehta, Khyati Y, et al. "Metabolomic biomarkers of pancreatic cancer: a meta-analysis study." Oncotarget vol. 8,40 (2017): 68899-68915. doi: https://doi.org/10.18632/oncotarget.20324
Mehta KY, Wu HJ, Menon SS, Fallah Y, Zhong X, Rizk N, Unger K, Mapstone M, Fiandaca MS, Federoff HJ, Cheema AK. Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget. 2017 Aug 18;8(40):68899-68915. doi: 10.18632/oncotarget.20324. eCollection 2017 Sep 15. PMID: 28978166; PMCID: PMC5620306.
Copy Download .nbib Format: NLM
Immediate .

ORAL & implantology

Milillo L, Fiandaca C, Giannoulis F, Ottria L, Lucchese A, Silvestre F, Petruzzi M.
PMID: 28042440
Oral Implantol (Rome). 2016 Nov 13;9(3):123-131. doi: 10.11138/orl/2016.9.3.123. eCollection 2016.

PURPOSE: This study aims to evaluate differences in implant stability between post-extractive implants MATERIALS AND METHODS: Patients were grouped into two different categories. In Group A 10 patients had an immediate post-extractive implant, then a provisional, acrylic resin crown...

Cite
Milillo L, Fiandaca C, Giannoulis F, et al. Immediate . Oral Implantol (Rome). 2016;9(3):123-131doi: 10.11138/orl/2016.9.3.123.
Milillo, L., Fiandaca, C., Giannoulis, F., Ottria, L., Lucchese, A., Silvestre, F., & Petruzzi, M. (2016). Immediate . ORAL & implantology, 9(3), 123-131. https://doi.org/10.11138/orl/2016.9.3.123
Milillo, L, et al. "Immediate ." ORAL & implantology vol. 9,3 (2016): 123-131. doi: https://doi.org/10.11138/orl/2016.9.3.123
Milillo L, Fiandaca C, Giannoulis F, Ottria L, Lucchese A, Silvestre F, Petruzzi M. Immediate . Oral Implantol (Rome). 2016 Nov 13;9(3):123-131. doi: 10.11138/orl/2016.9.3.123. eCollection 2016. PMID: 28042440; PMCID: PMC5159929.
Copy Download .nbib Format: NLM
Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease.

Frontiers in neurology

Fiandaca MS, Zhong X, Cheema AK, Orquiza MH, Chidambaram S, Tan MT, Gresenz CR, FitzGerald KT, Nalls MA, Singleton AB, Mapstone M, Federoff HJ.
PMID: 26617567
Front Neurol. 2015 Nov 12;6:237. doi: 10.3389/fneur.2015.00237. eCollection 2015.

We recently documented plasma lipid dysregulation in preclinical late-onset Alzheimer's disease (LOAD). A 10 plasma lipid panel, predicted phenoconversion and provided 90% sensitivity and 85% specificity in differentiating an at-risk group from those that would remain cognitively intact. Despite...

Cite
Fiandaca MS, Zhong X, Cheema AK, et al. Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease. Front Neurol. 2015;6:237doi: 10.3389/fneur.2015.00237.
Fiandaca, M. S., Zhong, X., Cheema, A. K., Orquiza, M. H., Chidambaram, S., Tan, M. T., Gresenz, C. R., FitzGerald, K. T., Nalls, M. A., Singleton, A. B., Mapstone, M., & Federoff, H. J. (2015). Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease. Frontiers in neurology, 6237. https://doi.org/10.3389/fneur.2015.00237
Fiandaca, Massimo S, et al. "Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease." Frontiers in neurology vol. 6 (2015): 237. doi: https://doi.org/10.3389/fneur.2015.00237
Fiandaca MS, Zhong X, Cheema AK, Orquiza MH, Chidambaram S, Tan MT, Gresenz CR, FitzGerald KT, Nalls MA, Singleton AB, Mapstone M, Federoff HJ. Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease. Front Neurol. 2015 Nov 12;6:237. doi: 10.3389/fneur.2015.00237. eCollection 2015. PMID: 26617567; PMCID: PMC4642213.
Copy Download .nbib Format: NLM
[Unemployment and morbidity. Observations on a group of 1,120 unemployed individuals hired at work. 1954].

La Medicina del lavoro

Fiandaca S, Brigatti L.
PMID: 11899933
Med Lav. 2001 Nov-Dec;92(6):431-5.

No abstract available.

Cite
Fiandaca S, Brigatti L. Disoccupazione e morbilità. Osservazioni su di un gruppo di 1.120 disoccupati assunti al lavoro. 1954. [Unemployment and morbidity. Observations on a group of 1,120 unemployed individuals hired at work. 1954]. Med Lav. 2001;92(6):431-5
Fiandaca, S., & Brigatti, L. (2001). Disoccupazione e morbilità. Osservazioni su di un gruppo di 1.120 disoccupati assunti al lavoro. 1954. [Unemployment and morbidity. Observations on a group of 1,120 unemployed individuals hired at work. 1954]. La Medicina del lavoro, 92(6), 431-5.
Fiandaca, S, and Brigatti, L. "Disoccupazione e morbilità. Osservazioni su di un gruppo di 1.120 disoccupati assunti al lavoro. 1954." [Unemployment and morbidity. Observations on a group of 1,120 unemployed individuals hired at work. 1954]. La Medicina del lavoro vol. 92,6 (2001): 431-5.
Fiandaca S, Brigatti L. Disoccupazione e morbilità. Osservazioni su di un gruppo di 1.120 disoccupati assunti al lavoro. 1954. [Unemployment and morbidity. Observations on a group of 1,120 unemployed individuals hired at work. 1954]. Med Lav. 2001 Nov-Dec;92(6):431-5. Italian. PMID: 11899933.
Copy Download .nbib Format: NLM
The quality of military medical reports.

United States Armed Forces medical journal

FIANDACA PM.
PMID: 13699286
U S Armed Forces Med J. 1960 Nov;11:1307-10.

No abstract available.

Cite
FIANDACA PM. The quality of military medical reports. U S Armed Forces Med J. 1960;11:1307-10
FIANDACA, P. M. (1960). The quality of military medical reports. United States Armed Forces medical journal, 111307-10.
FIANDACA, P M. "The quality of military medical reports." United States Armed Forces medical journal vol. 11 (1960): 1307-10.
FIANDACA PM. The quality of military medical reports. U S Armed Forces Med J. 1960 Nov;11:1307-10. PMID: 13699286.
Copy Download .nbib Format: NLM
Foetal bovine serum influence on in vitro extracellular vesicle analyses.

Journal of extracellular vesicles

Lehrich BM, Liang Y, Fiandaca MS.
PMID: 33532042
J Extracell Vesicles. 2021 Jan;10(3):e12061. doi: 10.1002/jev2.12061. Epub 2021 Jan 25.

No abstract available.

Cite
Lehrich BM, Liang Y, Fiandaca MS. Foetal bovine serum influence on in vitro extracellular vesicle analyses. J Extracell Vesicles. 2021;10(3):e12061doi: 10.1002/jev2.12061.
Lehrich, B. M., Liang, Y., & Fiandaca, M. S. (2021). Foetal bovine serum influence on in vitro extracellular vesicle analyses. Journal of extracellular vesicles, 10(3), e12061. https://doi.org/10.1002/jev2.12061
Lehrich, Brandon M, et al. "Foetal bovine serum influence on in vitro extracellular vesicle analyses." Journal of extracellular vesicles vol. 10,3 (2021): e12061. doi: https://doi.org/10.1002/jev2.12061
Lehrich BM, Liang Y, Fiandaca MS. Foetal bovine serum influence on in vitro extracellular vesicle analyses. J Extracell Vesicles. 2021 Jan;10(3):e12061. doi: 10.1002/jev2.12061. Epub 2021 Jan 25. PMID: 33532042; PMCID: PMC7830136.
Copy Download .nbib Format: NLM
Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signals.

Proceedings of the National Academy of Sciences of the United States of America

Ho PY, Zhang Z, Hayes ME, Curd A, Dib C, Rayburn M, Tam SN, Srivastava T, Hriniak B, Li XJ, Leonard S, Wang L, Tarighat S, Sim DS, Fiandaca M, Coull JM, Ebens A, Fordyce M, Czechowicz A.
PMID: 34732575
Proc Natl Acad Sci U S A. 2021 Nov 09;118(45). doi: 10.1073/pnas.2109175118.

Triplex gene editing relies on binding a stable peptide nucleic acid (PNA) sequence to a chromosomal target, which alters the helical structure of DNA to stimulate site-specific recombination with a single-strand DNA (ssDNA) donor template and elicits gene correction....

Cite
Ho PY, Zhang Z, Hayes ME, et al. Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signals. Proc Natl Acad Sci U S A. 2021;118(45)doi: 10.1073/pnas.2109175118.
Ho, P. Y., Zhang, Z., Hayes, M. E., Curd, A., Dib, C., Rayburn, M., Tam, S. N., Srivastava, T., Hriniak, B., Li, X. J., Leonard, S., Wang, L., Tarighat, S., Sim, D. S., Fiandaca, M., Coull, J. M., Ebens, A., Fordyce, M., & Czechowicz, A. (2021). Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signals. Proceedings of the National Academy of Sciences of the United States of America, 118(45), . https://doi.org/10.1073/pnas.2109175118
Ho, Pui Yan, et al. "Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signals." Proceedings of the National Academy of Sciences of the United States of America vol. 118,45 (2021). doi: https://doi.org/10.1073/pnas.2109175118
Ho PY, Zhang Z, Hayes ME, Curd A, Dib C, Rayburn M, Tam SN, Srivastava T, Hriniak B, Li XJ, Leonard S, Wang L, Tarighat S, Sim DS, Fiandaca M, Coull JM, Ebens A, Fordyce M, Czechowicz A. Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signals. Proc Natl Acad Sci U S A. 2021 Nov 09;118(45). doi: 10.1073/pnas.2109175118. PMID: 34732575; PMCID: PMC8609320.
Copy Download .nbib Format: NLM
[Results of an investigation on school orientation for the purpose of occupational training of young people].

La Medicina del lavoro

FIANDACA S, JACOBBI G.
PMID: 13822597
Med Lav. 1959 Nov;50:706-14.

No abstract available.

Cite
FIANDACA S, JACOBBI G. [Results of an investigation on school orientation for the purpose of occupational training of young people]. Med Lav. 1959;50:706-14
FIANDACA, S., & JACOBBI, G. (1959). [Results of an investigation on school orientation for the purpose of occupational training of young people]. La Medicina del lavoro, 50706-14.
FIANDACA, S, and JACOBBI, G. "[Results of an investigation on school orientation for the purpose of occupational training of young people]." La Medicina del lavoro vol. 50 (1959): 706-14.
FIANDACA S, JACOBBI G. [Results of an investigation on school orientation for the purpose of occupational training of young people]. Med Lav. 1959 Nov;50:706-14. Italian. PMID: 13822597.
Copy Download .nbib Format: NLM
[Professional responsibility of the physician].

Annali dell'Ospedale Maria Vittoria di Torino

Fiandaca S.
PMID: 1236436
Ann Osp Maria Vittoria Torino. 1975 Jul-Dec;18(7):167-83.

No abstract available.

Cite
Fiandaca S. La responsabilita' professionale del medico. [Professional responsibility of the physician]. Ann Osp Maria Vittoria Torino. 1975;18(7):167-83
Fiandaca, S. (1975). La responsabilita' professionale del medico. [Professional responsibility of the physician]. Annali dell'Ospedale Maria Vittoria di Torino, 18(7), 167-83.
Fiandaca, S. "La responsabilita' professionale del medico." [Professional responsibility of the physician]. Annali dell'Ospedale Maria Vittoria di Torino vol. 18,7 (1975): 167-83.
Fiandaca S. La responsabilita' professionale del medico. [Professional responsibility of the physician]. Ann Osp Maria Vittoria Torino. 1975 Jul-Dec;18(7):167-83. Italian. PMID: 1236436.
Copy Download .nbib Format: NLM
Author Correction: Plasma microRNA markers of upper limb recovery following human stroke.

Scientific reports

Edwardson MA, Zhong X, Fiandaca MS, Federoff HJ, Cheema AK, Dromerick AW.
PMID: 32034207
Sci Rep. 2020 Feb 07;10(1):2484. doi: 10.1038/s41598-020-58943-2.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Edwardson MA, Zhong X, Fiandaca MS, et al. Author Correction: Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep. 2020;10(1):2484doi: 10.1038/s41598-020-58943-2.
Edwardson, M. A., Zhong, X., Fiandaca, M. S., Federoff, H. J., Cheema, A. K., & Dromerick, A. W. (2020). Author Correction: Plasma microRNA markers of upper limb recovery following human stroke. Scientific reports, 10(1), 2484. https://doi.org/10.1038/s41598-020-58943-2
Edwardson, Matthew A, et al. "Author Correction: Plasma microRNA markers of upper limb recovery following human stroke." Scientific reports vol. 10,1 (2020): 2484. doi: https://doi.org/10.1038/s41598-020-58943-2
Edwardson MA, Zhong X, Fiandaca MS, Federoff HJ, Cheema AK, Dromerick AW. Author Correction: Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep. 2020 Feb 07;10(1):2484. doi: 10.1038/s41598-020-58943-2. PMID: 32034207; PMCID: PMC7005777.
Copy Download .nbib Format: NLM
Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications.

Pharmaceuticals (Basel, Switzerland)

Fiandaca MS, Bankiewicz KS, Federoff HJ.
PMID: 24281662
Pharmaceuticals (Basel). 2012 Jun 04;5(6):553-90. doi: 10.3390/ph5060553.

The pharmaceutical industry's development of therapeutic medications for the treatment of Parkinson's disease (PD) endures, as a result of the continuing need for better agents, and the increased clinical demand due to the aging population. Each new drug offers...

Cite
Fiandaca MS, Bankiewicz KS, Federoff HJ. Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications. Pharmaceuticals (Basel). 2012;5(6):553-90doi: 10.3390/ph5060553.
Fiandaca, M. S., Bankiewicz, K. S., & Federoff, H. J. (2012). Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications. Pharmaceuticals (Basel, Switzerland), 5(6), 553-90. https://doi.org/10.3390/ph5060553
Fiandaca, Massimo S, et al. "Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications." Pharmaceuticals (Basel, Switzerland) vol. 5,6 (2012): 553-90. doi: https://doi.org/10.3390/ph5060553
Fiandaca MS, Bankiewicz KS, Federoff HJ. Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications. Pharmaceuticals (Basel). 2012 Jun 04;5(6):553-90. doi: 10.3390/ph5060553. PMID: 24281662; PMCID: PMC3763661.
Copy Download .nbib Format: NLM
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC.

Cancers

Rajagopal MU, Bansal S, Kaur P, Jain SK, Altadil T, Hinzman CP, Li Y, Moulton J, Singh B, Bansal S, Chauthe SK, Singh R, Banerjee PP, Mapstone M, Fiandaca MS, Federoff HJ, Unger K, Smith JP, Cheema AK.
PMID: 34944824
Cancers (Basel). 2021 Dec 09;13(24). doi: 10.3390/cancers13246204.

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy wherein a majority of patients present metastatic disease at diagnosis. Although the role of epithelial to mesenchymal transition (EMT), mediated by transforming growth factor beta (TGFβ), in imparting an aggressive...

Cite
Rajagopal MU, Bansal S, Kaur P, et al. TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC. Cancers (Basel). 2021;13(24)doi: 10.3390/cancers13246204.
Rajagopal, M. U., Bansal, S., Kaur, P., Jain, S. K., Altadil, T., Hinzman, C. P., Li, Y., Moulton, J., Singh, B., Bansal, S., Chauthe, S. K., Singh, R., Banerjee, P. P., Mapstone, M., Fiandaca, M. S., Federoff, H. J., Unger, K., Smith, J. P., & Cheema, A. K. (2021). TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC. Cancers, 13(24), . https://doi.org/10.3390/cancers13246204
Rajagopal, Meena U, et al. "TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC." Cancers vol. 13,24 (2021). doi: https://doi.org/10.3390/cancers13246204
Rajagopal MU, Bansal S, Kaur P, Jain SK, Altadil T, Hinzman CP, Li Y, Moulton J, Singh B, Bansal S, Chauthe SK, Singh R, Banerjee PP, Mapstone M, Fiandaca MS, Federoff HJ, Unger K, Smith JP, Cheema AK. TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC. Cancers (Basel). 2021 Dec 09;13(24). doi: 10.3390/cancers13246204. PMID: 34944824.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries